Samantha Semenkow
Stock Analyst at Citigroup
(3.53)
# 838
Out of 5,163 analysts
73
Total ratings
47.54%
Success rate
6.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOA BioAge Labs | Maintains: Buy | $15 → $52 | $18.72 | +177.78% | 6 | Mar 10, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $38 → $46 | $27.85 | +65.17% | 2 | Mar 5, 2026 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $33 → $35 | $23.23 | +50.67% | 4 | Mar 3, 2026 | |
| LRMR Larimar Therapeutics | Maintains: Buy | $12 → $14 | $4.60 | +204.68% | 7 | Feb 25, 2026 | |
| CGEM Cullinan Therapeutics | Initiates: Buy | $33 | $13.49 | +144.63% | 1 | Feb 17, 2026 | |
| ROIV Roivant Sciences | Maintains: Buy | $26 → $35 | $28.06 | +24.73% | 4 | Feb 10, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,124 → $1,091 | $700.45 | +55.76% | 8 | Jan 8, 2026 | |
| FOLD Amicus Therapeutics | Downgrades: Neutral | $17 → $15 | $14.38 | +0.87% | 2 | Dec 22, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $64 | $39.89 | +60.44% | 1 | Dec 17, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $16 → $30 | $13.02 | +130.41% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $100 | $53.75 | +86.05% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $102 | $73.25 | +39.25% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $136 | $87.38 | +55.64% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $14 | $9.58 | +46.14% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4.25 | $3.65 | +16.44% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $17.13 | -70.81% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $3.06 | +226.80% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $2.40 | +66.67% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.46 | +169.36% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $3.36 | +346.43% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $32.28 | +147.83% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.44 | +514.75% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $24.41 | +104.83% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $25.16 | +122.58% | 3 | Aug 9, 2023 |
BioAge Labs
Mar 10, 2026
Maintains: Buy
Price Target: $15 → $52
Current: $18.72
Upside: +177.78%
Agios Pharmaceuticals
Mar 5, 2026
Maintains: Buy
Price Target: $38 → $46
Current: $27.85
Upside: +65.17%
Catalyst Pharmaceuticals
Mar 3, 2026
Maintains: Buy
Price Target: $33 → $35
Current: $23.23
Upside: +50.67%
Larimar Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $12 → $14
Current: $4.60
Upside: +204.68%
Cullinan Therapeutics
Feb 17, 2026
Initiates: Buy
Price Target: $33
Current: $13.49
Upside: +144.63%
Roivant Sciences
Feb 10, 2026
Maintains: Buy
Price Target: $26 → $35
Current: $28.06
Upside: +24.73%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $1,124 → $1,091
Current: $700.45
Upside: +55.76%
Amicus Therapeutics
Dec 22, 2025
Downgrades: Neutral
Price Target: $17 → $15
Current: $14.38
Upside: +0.87%
Spyre Therapeutics
Dec 17, 2025
Initiates: Buy
Price Target: $64
Current: $39.89
Upside: +60.44%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $16 → $30
Current: $13.02
Upside: +130.41%
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $53.75
Upside: +86.05%
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $73.25
Upside: +39.25%
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $87.38
Upside: +55.64%
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $9.58
Upside: +46.14%
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.65
Upside: +16.44%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $17.13
Upside: -70.81%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $3.06
Upside: +226.80%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.40
Upside: +66.67%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.46
Upside: +169.36%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $3.36
Upside: +346.43%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $32.28
Upside: +147.83%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.44
Upside: +514.75%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $24.41
Upside: +104.83%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $25.16
Upside: +122.58%